EMS115h
Nalmefene vs. Naloxone: Opioid-reversal drug research
What you need to know about opioid overdose reversal drug nalmefene’s risks, effectiveness and clinical concerns ...
The Times of Northwest Indiana21h
What we know about Narcan availability and its impact on overdose death rates in Northwest Indiana
This spring, the City of Gary will debut Narcan vending machines around town that will distribute the opioid overdose ...
Nature5d
Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative
Inflammatory and injury-induced skeletal pain are common conditions, and both conventional nonselective NSAIDs and the newer cyclo-oxygenase-2-specific inhibitors are widely used as post-traumatic ...
RedChip Companies, Inc.: Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV
ORLANDO, FL / ACCESS Newswire / March 14, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and Calidi Biotherapeutics, Inc. (NYSE American:CLDI) on the RedChip S ...